Internal Medicine 919 - Internal Medicine Alert - Oct 15, 2005

Target Audience:

This activity is intended for the internist and family practitioner.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 1.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Subjects:

  • Even If You Use It, You May Lose It!
  • Effect of a New Diagnosis of Barrett’s Esophagus on Insurance Status
  • Increased Dietary Intake of Folate Reduces the Risk of Developing Alzheimer’s Disease
  • Pharmacology Update: Ramelteon Tablets (Rozerem™)
  • Clinical Briefs
  • ECG Review: When Did the Chest Pain Begin?

Objectives:

  • Describe new findings in differential diagnosis and treatment of various diseases
  • Describe controversies, advantages, and disadvantages of those advances
  • Describe cost-effective treatment regimens

Financial Disclosure:

Internal Medicine Alert’s Editor, Stephen Brunton, MD, is a consultant for Sanofi-Aventis, Ortho-McNeil, McNeil, Abbott, Novo Nordisk, Eli Lilly, Endo, EXACT Sciences, and Astra-Zeneca and serves on the speaker’s bureau of McNeil, Sanofi-Aventis, and Ortho-McNeil.